Back to Stakeholders

Washington State's health technology assessment function supporting evidence review and state-level coverage policy processes that can influence psychedelic-adjacent reimbursement environments.

Reimbursement & Market Access Snapshot

Health Economists

Service Model

HTA / Value Assessment Body

Jurisdiction

Subnational / State-Level

Coverage

1 country

Last Verified

Apr 11, 2026

Focus Areas

HTA Evidence AppraisalCoverage Policy Design

Evidence Requirements

Clinical Efficacy EndpointsComparative EffectivenessCost-Effectiveness

Market Access Notes

Washington HTA serves as a state coverage-evidence mechanism relevant to future psychedelic market access pathways.

Verification

Verified

Psychedelic Focus

No Public Psychedelic Focus

Engagement Status

Active

Verification Notes

Verified as an active state HTA body with formal evidence-review and coverage-decision role; no explicit psychedelic-specific publication confirmed in this pass.

Primary Access Link

Quick Facts

Website
Visit